Pulmonary heart disease, also known as cor pulmonale, is a condition characterized by the enlargement and dysfunction of the right side of the heart. This condition is typically a consequence of prolonged high blood pressure in the pulmonary arteries, which are responsible for carrying blood from the heart to the lungs. Chronic respiratory conditions such as chronic obstructive pulmonary disease (COPD), pulmonary hypertension, and interstitial lung diseases are common contributors to the development of pulmonary heart disease. The increased resistance in the pulmonary circulation forces the right side of the heart to pump harder, leading to its enlargement and potential failure over time. Indications may involve difficulty breathing, tiredness, and edema in the legs. Timely diagnosis and management of the underlying respiratory condition are crucial in addressing and preventing the progression of pulmonary heart disease.
Title : Fats of Life, the skinny on statins and beyond !
Ahdy Wadie Helmy, Indiana University School of Medicine, United States
Title : Pharmacological advancement in pulmonary arterial hypertension treatment - Contribution of treprostinil dry-powder formulation
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Personalized and Precision Medicine (PPM) and PPN-guided cardiology practice as a unique model via translational applications and upgraded business modeling to secure human healthcare, wellness and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Cardiovascular nanomedicine: Stopping strokes, unclogging arteries and restoring heart function
Thomas J Webster, Hebei University of Technology, China
Title : Antibodies with functionality as a new generation of translational tools designed to monitor autoimmune myocarditis at clinical and subclinical stages
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Perception of cardiovascular risk in women after a rehabilitation program
Maria Teresa Carvallo Marin, Privado, Chile